Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

TARGET 2.0 Study: Safety and Performance of the Cardiovalve Tricuspid Valve Replacement System in the Treatment of Subjects With Tricuspid Regurgitation- Investigation

NCT07334691 is registered in ClinicalTrials.gov with Cardiovalve Ltd. as lead sponsor.

NCT NCT07334691
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07334691 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
TARGET 2.0 Study: Safety and Performance of the Cardiovalve Tricuspid Valve Replacement System in the Treatment of Subjects With Tricuspid Regurgitation- Investigation
Lead sponsor
Cardiovalve Ltd.
Phase
Not applicable
Overall status
Recruiting
Start date
January 20, 2026
Completion date
September 30, 2033
Enrollment
150 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

tricuspid regurgitation